Sigachi Industries Limited (NSE:SIGACHI)
30.05
-0.26 (-0.86%)
Aug 21, 2026, 3:29 PM IST
Sigachi Industries Revenue
Sigachi Industries had revenue of 1.22B INR in the quarter ending June 30, 2026, a decrease of -4.65%. This brings the company's revenue in the last twelve months to 4.76B, down -8.56% year-over-year. In the fiscal year ending March 31, 2026, Sigachi Industries had annual revenue of 4.86B, down -2.85%.
Revenue (ttm)
4.76B
Revenue Growth
-8.56%
P/S Ratio
2.41
Revenue / Employee
3.16M
Employees
1,507
Market Cap
11.48B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 4.86B | -142.47M | -2.85% |
| Mar 31, 2025 | 5.00B | 962.25M | 23.81% |
| Mar 31, 2024 | 4.04B | 1.02B | 33.79% |
| Mar 31, 2023 | 3.02B | 517.55M | 20.68% |
| Mar 31, 2022 | 2.50B | 544.85M | 27.83% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Indoco Remedies | 18.73B |
| Solara Active Pharma Sciences | 14.31B |
| Windlas Biotech | 9.42B |
| RPG Life Sciences | 7.34B |
| Ind-Swift Laboratories | 6.74B |
| Beta Drugs | 4.10B |
| Valiant Laboratories | 3.06B |
| Jagsonpal Pharmaceuticals | 2.94B |